异动解读 | 财报超预期且业绩指引强劲，卡地纳健康盘中大涨5.41%

异动解读

Yesterday

卡地纳健康（CAH）今日盘中股价大涨5.41%，引发市场广泛关注。

消息面上，公司发布的最新财报与业绩展望成为股价上涨的核心催化剂。卡地纳健康公布的2026财年第四季度财报显示，调整后每股收益达到2.91美元，大幅超出市场预期的2.42美元，超预期幅度约为20%。在剔除一次性关税退还收益后，其经调整每股收益仍同比增长25%至2.60美元，显示出主营业务的稳健增长动能。受品牌药和专科药需求推动，公司最大的业务部门——制药与专科解决方案部门本季度销售额同比增长6%，达到554亿美元。

更为关键的是，公司对2027财年给出了极为乐观的业绩指引。卡地纳健康预计全年经调整后每股收益将在12.40美元至12.60美元之间，对应同比增速13%至15%，显著高于分析师平均预期的12.04美元。公司将此归因于专科药品需求的持续强劲，以及近期对AdaptHealth糖尿病健康业务和Strive Medical等补充性收购的贡献。与此同时，公司董事会批准了高达50亿美元的增量股票回购授权，并计划在2027财年回购约10亿美元股份，进一步向市场传递了管理层对公司长期价值的信心。强劲的盈利表现、超预期的业绩展望以及大规模回购计划三重利好叠加，共同推动了卡地纳健康今日盘中股价的显著上涨。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1190218090"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1190218090\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1190218090?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-08-11 21:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190218090","market":"hk","top_or_hot":-1,"title":"异动解读 | 财报超预期且业绩指引强劲，卡地纳健康盘中大涨5.41%","media":"异动解读","content":"<p>卡地纳健康（CAH）今日盘中股价大涨5.41%，引发市场广泛关注。</p><p>消息面上，公司发布的最新财报与业绩展望成为股价上涨的核心催化剂。卡地纳健康公布的2026财年第四季度财报显示，调整后每股收益达到2.91美元，大幅超出市场预期的2.42美元，超预期幅度约为20%。在剔除一次性关税退还收益后，其经调整每股收益仍同比增长25%至2.60美元，显示出主营业务的稳健增长动能。受品牌药和专科药需求推动，公司最大的业务部门——制药与专科解决方案部门本季度销售额同比增长6%，达到554亿美元。</p><p>更为关键的是，公司对2027财年给出了极为乐观的业绩指引。卡地纳健康预计全年经调整后每股收益将在12.40美元至12.60美元之间，对应同比增速13%至15%，显著高于分析师平均预期的12.04美元。公司将此归因于专科药品需求的持续强劲，以及近期对AdaptHealth糖尿病健康业务和Strive Medical等补充性收购的贡献。与此同时，公司董事会批准了高达50亿美元的增量股票回购授权，并计划在2027财年回购约10亿美元股份，进一步向市场传递了管理层对公司长期价值的信心。强劲的盈利表现、超预期的业绩展望以及大规模回购计划三重利好叠加，共同推动了卡地纳健康今日盘中股价的显著上涨。</p>","source":"ai_movement_cn","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | 财报超预期且业绩指引强劲，卡地纳健康盘中大涨5.41%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | 财报超预期且业绩指引强劲，卡地纳健康盘中大涨5.41%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092702339\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">异动解读 </p>\n<p class=\"h-time\">2026-08-11 21:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>卡地纳健康（CAH）今日盘中股价大涨5.41%，引发市场广泛关注。</p><p>消息面上，公司发布的最新财报与业绩展望成为股价上涨的核心催化剂。卡地纳健康公布的2026财年第四季度财报显示，调整后每股收益达到2.91美元，大幅超出市场预期的2.42美元，超预期幅度约为20%。在剔除一次性关税退还收益后，其经调整每股收益仍同比增长25%至2.60美元，显示出主营业务的稳健增长动能。受品牌药和专科药需求推动，公司最大的业务部门——制药与专科解决方案部门本季度销售额同比增长6%，达到554亿美元。</p><p>更为关键的是，公司对2027财年给出了极为乐观的业绩指引。卡地纳健康预计全年经调整后每股收益将在12.40美元至12.60美元之间，对应同比增速13%至15%，显著高于分析师平均预期的12.04美元。公司将此归因于专科药品需求的持续强劲，以及近期对AdaptHealth糖尿病健康业务和Strive Medical等补充性收购的贡献。与此同时，公司董事会批准了高达50亿美元的增量股票回购授权，并计划在2027财年回购约10亿美元股份，进一步向市场传递了管理层对公司长期价值的信心。强劲的盈利表现、超预期的业绩展望以及大规模回购计划三重利好叠加，共同推动了卡地纳健康今日盘中股价的显著上涨。</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CAH","symbol_name":"卡地纳健康","start_time":0,"source_url":"","article_id":"1190218090","we_media_id":"1092702339","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190218090","pubTimestamp":1786455271,"columns":[],"sourceInfo":{"source_id":"ai_movement_cn","name":"异动解读"},"weMediaInfo":{"media_name":"异动解读","introduction":"个股异动一手消息解读","home_visible":1,"id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"卡地纳健康今日盘中股价大涨5.41%，引发市场广泛关注。卡地纳健康公布的2026财年第四季度财报显示，调整后每股收益达到2.91美元，大幅超出市场预期的2.42美元，超预期幅度约为20%。卡地纳健康预计全年经调整后每股收益将在12.40美元至12.60美元之间，对应同比增速13%至15%，显著高于分析师平均预期的12.04美元。强劲的盈利表现、超预期的业绩展望以及大规模回购计划三重利好叠加，共同推动了卡地纳健康今日盘中股价的显著上涨。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"CAH":"卡地纳健康"},"translate_title":"Interpretation of the change | The financial report exceeded expectations and the performance guidance was strong, and Cardinal Health rose 5.41% in the intraday session","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CAH":1},"content_text":"卡地纳健康（CAH）今日盘中股价大涨5.41%，引发市场广泛关注。消息面上，公司发布的最新财报与业绩展望成为股价上涨的核心催化剂。卡地纳健康公布的2026财年第四季度财报显示，调整后每股收益达到2.91美元，大幅超出市场预期的2.42美元，超预期幅度约为20%。在剔除一次性关税退还收益后，其经调整每股收益仍同比增长25%至2.60美元，显示出主营业务的稳健增长动能。受品牌药和专科药需求推动，公司最大的业务部门——制药与专科解决方案部门本季度销售额同比增长6%，达到554亿美元。更为关键的是，公司对2027财年给出了极为乐观的业绩指引。卡地纳健康预计全年经调整后每股收益将在12.40美元至12.60美元之间，对应同比增速13%至15%，显著高于分析师平均预期的12.04美元。公司将此归因于专科药品需求的持续强劲，以及近期对AdaptHealth糖尿病健康业务和Strive Medical等补充性收购的贡献。与此同时，公司董事会批准了高达50亿美元的增量股票回购授权，并计划在2027财年回购约10亿美元股份，进一步向市场传递了管理层对公司长期价值的信心。强劲的盈利表现、超预期的业绩展望以及大规模回购计划三重利好叠加，共同推动了卡地纳健康今日盘中股价的显著上涨。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}